OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors
Valentina N. Lagomarsino, Richard V. Pearse, Lei Liu, et al.
Neuron (2021) Vol. 109, Iss. 21, pp. 3402-3420.e9
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration
Dylan V. Neel, Himanish Basu, Georgia Gunner, et al.
Neuron (2023) Vol. 111, Iss. 8, pp. 1222-1240.e9
Open Access | Times Cited: 65

Cell subtype-specific effects of genetic variation in the Alzheimer’s disease brain
Masashi Fujita, Zongmei Gao, Lu Zeng, et al.
Nature Genetics (2024) Vol. 56, Iss. 4, pp. 605-614
Closed Access | Times Cited: 60

Moving beyond amyloid and tau to capture the biological heterogeneity of Alzheimer’s disease
Tracy L. Young‐Pearse, Hyo Lee, Yi‐Chen Hsieh, et al.
Trends in Neurosciences (2023) Vol. 46, Iss. 6, pp. 426-444
Open Access | Times Cited: 48

Neuroinflammation in Alzheimer disease
Wiesje M. van der Flier, Wiesje M. van der Flier, Frank Jessen, et al.
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 16

VLDLR and ApoER2 are receptors for multiple alphaviruses
Lars E. Clark, Sarah A. Clark, ChieYu Lin, et al.
Nature (2021) Vol. 602, Iss. 7897, pp. 475-480
Open Access | Times Cited: 84

Identification of the Aβ37/42 peptide ratio in CSF as an improved Aβ biomarker for Alzheimer's disease
Lei Liu, Bianca M. Lauro, Amy He, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 1, pp. 79-96
Closed Access | Times Cited: 41

A locus at 19q13.31 significantly reduces the ApoE ε4 risk for Alzheimer’s Disease in African Ancestry
Farid Rajabli, Gary W. Beecham, Hugh C. Hendrie, et al.
PLoS Genetics (2022) Vol. 18, Iss. 7, pp. e1009977-e1009977
Open Access | Times Cited: 40

INPP5D regulates inflammasome activation in human microglia
Vicky Chou, Richard V. Pearse, Aimee J. Aylward, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 33

Neurodegeneration cell per cell
Sriram Balusu, Roman Praschberger, Elsa Lauwers, et al.
Neuron (2023) Vol. 111, Iss. 6, pp. 767-786
Open Access | Times Cited: 30

Brain organoids are new tool for drug screening of neurological diseases
Chong Gao, Jin-Qi Zhou, Linghui Zeng, et al.
Neural Regeneration Research (2023)
Open Access | Times Cited: 29

Cell-type-specific regulation of APOE and CLU levels in human neurons by the Alzheimer’s disease risk gene SORL1
Hyo Lee, Aimee J. Aylward, Richard V. Pearse, et al.
Cell Reports (2023) Vol. 42, Iss. 8, pp. 112994-112994
Open Access | Times Cited: 25

Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond
Elise K. Webber, Marc Fivaz, Grace E. Stutzmann, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 8, pp. 3701-3717
Open Access | Times Cited: 23

Genome-wide CRISPR screen identifies neddylation as a regulator of neuronal aging and AD neurodegeneration
Nathalie Saurat, Andrew P. Minotti, Maliha T. Rahman, et al.
Cell stem cell (2024) Vol. 31, Iss. 8, pp. 1162-1174.e8
Open Access | Times Cited: 12

Protecting Human and Animal Health: The Road from Animal Models to New Approach Methods
Barbara L.F. Kaplan, Alan M. Hoberman, William Slikker, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 2, pp. 251-266
Open Access | Times Cited: 9

Patient iPSC models reveal glia-intrinsic phenotypes in multiple sclerosis
Benjamin L.L. Clayton, Lilianne Barbar, Maria L. Sapar, et al.
Cell stem cell (2024) Vol. 31, Iss. 11, pp. 1701-1713.e8
Open Access | Times Cited: 9

Strategies for modeling aging and age-related diseases
D. Jothi, Linda Anna Michelle Kulka
npj Aging (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8

Cell-subtype specific effects of genetic variation in the aging and Alzheimer cortex
Masashi Fujita, Zongmei Gao, Lu Zeng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 30

The future of stem cell therapies of Alzheimer’s disease
Zhibo Wang, Zuo-Teng Wang, Yan Sun, et al.
Ageing Research Reviews (2022) Vol. 80, pp. 101655-101655
Closed Access | Times Cited: 29

Bridging the rodent to human translational gap: Marmosets as model systems for the study of Alzheimer's disease
Stacey J. Sukoff Rizzo, Gregg E. Homanics, David J. Schaeffer, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2023) Vol. 9, Iss. 3
Open Access | Times Cited: 21

Small molecule regulators of microRNAs identified by high-throughput screen coupled with high-throughput sequencing
Lien D. Nguyen, Zhiyun Wei, M. Catarina Silva, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 21

Neuronal-Activity Dependent Mechanisms of Small Cell Lung Cancer Progression
Solomiia Savchuk, Kaylee M. Gentry, Wengang Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 18

CRISPR-based functional genomics screening in human-pluripotent-stem-cell-derived cell types
Kun Li, Miao Ou-Yang, Jiangshan Zhan, et al.
Cell Genomics (2023) Vol. 3, Iss. 5, pp. 100300-100300
Open Access | Times Cited: 18

The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer’s Disease
Katja Maria Bendtsen, Vanessa Jane Hall
Cells (2023) Vol. 12, Iss. 3, pp. 420-420
Open Access | Times Cited: 17

Page 1 - Next Page

Scroll to top